Diseases requiring pancreatoduodenectomy (e.g., pancreatic cancer, bile duct cancer)
Conditions
Interventions
None listed
Sponsors
Shizuoka Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients for whom pancreatoduodenectomy is being planned 2. Patients must be 18 years of age or older at the time of enrollment. 3. including patients who underwent preoperative chemotherapy and/or radiation therapy 4. Patients who do not have severe disorders of major organs (liver, kidney, etc.) and meet the following criteria on clinical examination a White blood cell count >=3,000/mm3 b Neutrophil count: >=1,000/mm3 c Hemoglobin: >=9.0g/dL d Platelet count: >=100,000/mm3 e AST:<=100U/L, ALT:<=100U/L f Total bilirubin: <=5mg/dL g Creatinine: <=2mg/dL 5. Written consent has been obtained from the patient
Exclusion criteria
Exclusion criteria: 1. Patients scheduled for hepato-pancreatpduedenectomy 2. Patients scheduled for pancreatic total resection (including residual pancreatectomy) 3. patients with psychiatric or neurological symptoms 4. patients who are judged to be difficult to perform the 6-minute walk test 5. patients who are deemed unsuitable for enrollment in this study by the physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients with decreased quality of life in the perioperative period after pancreaticoduodenectomy | — |
Countries
Japan
Contacts
Public ContactTeiichi Sugiura
Shizuoka Cancer Center Division of Hepato-Biliary-Pancreatic Surgery
Outcome results
None listed